Stereotactic body radiation therapy in elderly patients with spinal metastases

PURPOSE: Elderly patients with spinal metastases are often considered poor candidates for aggressive local therapy, due in part to medical comorbidity and limited evidence to guide treatment selection. This study evaluated outcomes following spine stereotactic body radiation therapy (SBRT) in this patient population and examined predictors of local failure (LF) and vertebral compression fracture (VCF). METHODS: A prospectively maintained database of consecutive patients aged ≥ 70 years with available imaging who underwent spine SBRT at a quaternary referral center from 2002 to 2024 was analyzed. The median single-fraction dose was 16 Gy (range: 12-18 Gy), and multi-fraction regimens ranged from 18 to 35 Gy in 2-5 fractions. RESULTS: Of 208 metastases in 161 patients (median age: 75 years, range: 70-94 years), 72% had prior conventional radiotherapy and 76% received a single fraction. The 6-, 12-, 24-, and 36-month cumulative incidence rates were 6%, 9%, 9%, and 10% for LF and 4%, 7%, 8%, and 9% for VCF (median follow-up: 9 months, range: 1-132 months). Gross tumor volume > 37 cc (subdistribution hazard ratio [sHR]: 6.27, 95% confidence interval [CI]: 1.48-26.63, P = 0.013) and Spinal Instability Neoplastic Score (SINS, per-point sHR: 1.23, 95% CI: 1.07-1.42, P = 0.005) were independently associated with LF; only SINS was independently associated with VCF (per-point sHR: 1.19, 95% CI: 1.06-1.34, P = 0.003), and 11 of 17 VCFs required cement augmentation or surgery. Age was associated with overall survival (hazard ratio: 1.05 per year, 95% CI: 1.01-1.09, P = 0.018); no statistically significant association was detected with LF or VCF when age was analyzed continuously, at thresholds of 75 or 80 years, or by exploratory maximally selected rank statistical analysis. Complete or partial pain response followed 61 of 148 evaluable treatments (41%) among 186 symptomatic metastases, and 18% of patients had grade 1-2 radiation toxicity. CONCLUSION: Spine SBRT, predominantly single-fraction reirradiation, was associated with low rates of LF and VCF; chronologic age alone should not preclude its use in appropriately selected elderly patients.

Authors

Institutions

Publication Details

Journal
Journal of Neuro-Oncology
Published
2026-10-16
DOI
https://doi.org/10.1007/s11060-026-05838-3
Primary Topic
Management of metastatic bone disease
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Stereotactic body radiation therapy in elderly patients with spinal metastases

Suchet Taori, James C. Bayley, Andrew H. Zureick, John C. Flíckinger et al.
Journal of Neuro-Oncology
Management of metastatic bone disease
article

Stereotactic body radiation therapy in elderly patients with spinal metastases

Suchet Taori, James C. Bayley, Andrew H. Zureick, John C. Flíckinger, Brock J. Gjesdal, Roberta Kay Sefcik, Peter Carlos Gerszten, Pascal Olivier Zinn, Samuel Adida, Serah Choi
article en

Abstract

PURPOSE: Elderly patients with spinal metastases are often considered poor candidates for aggressive local therapy, due in part to medical comorbidity and limited evidence to guide treatment selection. This study evaluated outcomes following spine stereotactic body radiation therapy (SBRT) in this patient population and examined predictors of local failure (LF) and vertebral compression fracture (VCF). METHODS: A prospectively maintained database of consecutive patients aged ≥ 70 years with available imaging who underwent spine SBRT at a quaternary referral center from 2002 to 2024 was analyzed. The median single-fraction dose was 16 Gy (range: 12-18 Gy), and multi-fraction regimens ranged from 18 to 35 Gy in 2-5 fractions. RESULTS: Of 208 metastases in 161 patients (median age: 75 years, range: 70-94 years), 72% had prior conventional radiotherapy and 76% received a single fraction. The 6-, 12-, 24-, and 36-month cumulative incidence rates were 6%, 9%, 9%, and 10% for LF and 4%, 7%, 8%, and 9% for VCF (median follow-up: 9 months, range: 1-132 months). Gross tumor volume > 37 cc (subdistribution hazard ratio [sHR]: 6.27, 95% confidence interval [CI]: 1.48-26.63, P = 0.013) and Spinal Instability Neoplastic Score (SINS, per-point sHR: 1.23, 95% CI: 1.07-1.42, P = 0.005) were independently associated with LF; only SINS was independently associated with VCF (per-point sHR: 1.19, 95% CI: 1.06-1.34, P = 0.003), and 11 of 17 VCFs required cement augmentation or surgery. Age was associated with overall survival (hazard ratio: 1.05 per year, 95% CI: 1.01-1.09, P = 0.018); no statistically significant association was detected with LF or VCF when age was analyzed continuously, at thresholds of 75 or 80 years, or by exploratory maximally selected rank statistical analysis. Complete or partial pain response followed 61 of 148 evaluable treatments (41%) among 186 symptomatic metastases, and 18% of patients had grade 1-2 radiation toxicity. CONCLUSION: Spine SBRT, predominantly single-fraction reirradiation, was associated with low rates of LF and VCF; chronologic age alone should not preclude its use in appropriately selected elderly patients.

Journal of Neuro-OncologyVol. 180(2)
Medical University of South Carolina (US), University of Pittsburgh Medical Center (US)
Good health and well-being
Openalex Percentile: Top 10%
Management of metastatic bone disease
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.